Skip to content

DR STEFFENS YOUNES

Active Private limited companyfounded 2023active for 3 yearsRue de l'Union 54, 7540 TournaiKBO/BCE: BE 1001.903.892

Lifetime

2 annual accounts with figures on one time axis
Gross marginpeak €293,850 (2025)
€293,850▲ 12.2%
Resultpeak €220,132 (2025)
€220,132▲ 13.5%
Equitypeak €419,127 (2025)
€419,127▲ 111%
Debts
€133,712▲ 65.2%
Board1 name since 2023
1 directorSTEFFENS Younes Frans Abdel
Documentsfilings and deeds
25-09-202656 days late
2025micro format
Gross margin from €261,907 to €293,850Equity from €198,995 to €419,127Debts from €80,954 to €133,712Investments €11,452Cash from €106,508 to €232,638

Key points

from the 2025 annual accounts

Equity

€419,127 ▲ 111%
€199,0002024€419,0002025

Equity rose in 2025 from €198,995 to €419,127.

Turnover

≈ €590,000 estimated

The micro format states no turnover.

Investments

€11,452 2.0 × depreciation
20242025

Green is investment, beige is depreciation. Machinery stands 24.2% higher than in 2024.

2025 accounts filed 56 days after the deadline

Checked score

96
Excellent
Financially stronger than 87% of micro companies without a NACE code
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 2.4% 01-2025: 2.4%● unchanged vs 12-2024 02-2025: 2.9%▲ +0.5 percentage points vs 01-2025 03-2025: 3.0%▲ +0.1 percentage points vs 02-2025 04-2025: 3.3%▲ +0.3 percentage points vs 03-2025 05-2025: 3.3%● unchanged vs 04-2025 06-2025: 3.6%▲ +0.3 percentage points vs 05-2025 07-2025: 3.5%▼ -0.1 percentage points vs 06-2025 08-2025: 3.4%▼ -0.1 percentage points vs 07-2025 09-2025: 3.5%▲ +0.1 percentage points vs 08-2025 10-2025: 3.8%▲ +0.3 percentage points vs 09-2025highest value 11-2025: 0.3%▼ -3.5 percentage points vs 10-2025 12-2025: 0.3%● unchanged vs 11-2025 01-2026: 0.3%● unchanged vs 12-2025 02-2026: 0.3%● unchanged vs 01-2026 03-2026: 0.3%● unchanged vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.3%● unchanged vs 06-2026 08-2026: 0.6%▲ +0.3 percentage points vs 07-2026 09-2026: 0.7%▲ +0.1 percentage points vs 08-2026 10-2026: 0.1%▼ -0.6 percentage points vs 09-2026lowest value 11-2026: 0.1%● unchanged vs 10-2026lowest value

Financial strength
Strong

Solvency
100+4equity 75.8% of total assets
Liquidity
91+5short-term debt 24.2% · cash 42.1%
Profitability
100=return on assets 39.8%

Score breakdown

raises risk
Last filed accounts filed 56 days late; 2 of the last 3 accounts late
lowers risk
Size: total assets €552,839
Liquidity: current ratio 3.96, cash €232,638
No main activity registered
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 81% of them on solvency, 82% on liquidity, 90% on profitability and 93% on growth.

The bankruptcy probability was computed on 05-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 3,127 companies had the same profile as DR STEFFENS YOUNES has now. Each dot stands for 8 companies, two years later.

97.2%
were still trading
1.9%
stopped another way
0.8%
went bankrupt
  • Small
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

That fits the bankruptcy probability of DR STEFFENS YOUNES itself: 0.1% within 12 months.

Test of the method

The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 3,127 companies, not a prediction for DR STEFFENS YOUNES. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €40,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 3.96 (3.25 in 2024), above the usual 1.5. Short-term debt is 24.2% and cash 42.1% of total assets. 24.2% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises risk
lowers risk · Size: total assets €552,839
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Last filed accounts filed 56 days late; 2 of the last 3 accounts late
NBB · filings
lowers risk · Liquidity: current ratio 3.96, cash €232,638
NBB · annual accounts
lowers risk · No main activity registered
KBO
raises risk · 2025 accounts filed 56 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 25-09-2026, 56 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 2 filings
Deviation from the deadline
2025
56 days late
2024
61 days late
← before the deadline after the deadline →
tick = median of all Belgian filings

The company filed its last 2 accounts on average 59 days after the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
06-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2023.
KBO publications

Board and ownership

  • STEFFENS Younes Frans Abdel 100 sharesdeed of 07-11-2023
Board & ownership

Recent changes

Incorporation Founding capital of €5,000, 100 shares · Founder: STEFFENS Younes Frans Abdel (comparant) · Appointment: STEFFENS Younes Frans Abdel (director) · published on 07-11-2023 · Gazette deed
First establishment Rue de l'Union 54, Tournai
All 5 events

Official details

Source: KBO
Status
Active since 03-11-2023Normal situation
Activity
“L'exercice de la médecine et tout particulièrement, la spécialisation en Oto-Rhino-Laryngologie, par organes médecins…” (deed in French)From the articles, 10 activitiesNo NACE code in the KBO yet
Establishment unit
2.351.487.3617540 Tournai, since 03-11-2023
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

Total assets
€552,839▲ 97.5%
Filing
Filed on 25-09-2026
Financials

Insights on DR STEFFENS YOUNES

DR STEFFENS YOUNES has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €419,127 and a net result of €220,132.

The computed 12-month bankruptcy probability is 0.1% (very low).

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR STEFFENS YOUNES

What is the company number of DR STEFFENS YOUNES?
The company number of DR STEFFENS YOUNES is 1001.903.892. The VAT number is the same number with BE in front: BE 1001.903.892.
Where is DR STEFFENS YOUNES based?
The registered office is at Rue de l'Union 54, 7540 Tournai.Company details
What is the legal form of DR STEFFENS YOUNES?
DR STEFFENS YOUNES is a private limited company (BV).
When was DR STEFFENS YOUNES founded?
DR STEFFENS YOUNES was founded on 03-11-2023.
Is DR STEFFENS YOUNES still active?
Yes, DR STEFFENS YOUNES is an active enterprise in the KBO register.
What is the turnover of DR STEFFENS YOUNES?
The turnover in financial year 2025 is ≈ €590,000. This figure is estimated from the gross margin of €293,850 and 882 comparable companies of the same size. It probably lies between €410,000 and €850,000. It is a rough estimate.Financials
Is DR STEFFENS YOUNES profitable?
In financial year 2025, DR STEFFENS YOUNES made a profit of €220,132.
Where can I find the annual accounts of DR STEFFENS YOUNES?
DR STEFFENS YOUNES filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR STEFFENS YOUNES due?
DR STEFFENS YOUNES must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.